Granulocyte-colony stimulating factor and umbilical cord blood cell transplantation: Synergistic therapies for the treatment of traumatic brain injury
Traumatic brain injury (TBI) is now characterized as a progressive, degenerative disease and continues to stand as a prevalent cause of death and disability. The pathophysiology of TBI is complex, with a variety of secondary cell death pathways occurring which may persist chronically following the i...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Brain Circulation |
Subjects: | |
Online Access: | http://www.braincirculation.org/article.asp?issn=2394-8108;year=2017;volume=3;issue=3;spage=143;epage=151;aulast=Liska |
id |
doaj-52131c084cc74ff6b4f4d7d736cc72b8 |
---|---|
record_format |
Article |
spelling |
doaj-52131c084cc74ff6b4f4d7d736cc72b82020-11-24T21:34:33ZengWolters Kluwer Medknow PublicationsBrain Circulation2394-81082455-46262017-01-013314315110.4103/bc.bc_19_17Granulocyte-colony stimulating factor and umbilical cord blood cell transplantation: Synergistic therapies for the treatment of traumatic brain injuryMichael G LiskaIke dela PeñaTraumatic brain injury (TBI) is now characterized as a progressive, degenerative disease and continues to stand as a prevalent cause of death and disability. The pathophysiology of TBI is complex, with a variety of secondary cell death pathways occurring which may persist chronically following the initial cerebral insult. Current therapeutic options for TBI are minimal, with surgical intervention or rehabilitation therapy existing as the only viable treatments. Considering the success of stem-cell therapies in various other neurological diseases, their use has been proposed as a potential potent therapy for patients suffering TBI. Moreover, stem cells are highly amenable to adjunctive use with other therapies, providing an opportunity to overcome the inherent limitations of using a single therapeutic agent. Our research has verified this additive potential by demonstrating the efficacy of co-delivering human umbilical cord blood (hUCB) cells with granulocyte-colony stimulating factor (G-CSF) in a murine model of TBI, providing encouraging results which support the potential of this approach to treat patients suffering from TBI. These findings justify ongoing research toward uncovering the mechanisms which underlie the functional improvements exhibited by hUCB + G-CSF combination therapy, thereby facilitating its safe and effect transition into the clinic. This paper is a review article. Referred literature in this paper has been listed in the reference section. The datasets supporting the conclusions of this article are available online by searching various databases, including PubMed. Some original points in this article come from the laboratory practice in our research center and the authors' experiences.http://www.braincirculation.org/article.asp?issn=2394-8108;year=2017;volume=3;issue=3;spage=143;epage=151;aulast=LiskaCentral nervous system disordersgranulocyte-colony stimulating factorhuman umbilical cord bloodregenerative medicinestem-cell therapytraumatic brain injury |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Michael G Liska Ike dela Peña |
spellingShingle |
Michael G Liska Ike dela Peña Granulocyte-colony stimulating factor and umbilical cord blood cell transplantation: Synergistic therapies for the treatment of traumatic brain injury Brain Circulation Central nervous system disorders granulocyte-colony stimulating factor human umbilical cord blood regenerative medicine stem-cell therapy traumatic brain injury |
author_facet |
Michael G Liska Ike dela Peña |
author_sort |
Michael G Liska |
title |
Granulocyte-colony stimulating factor and umbilical cord blood cell transplantation: Synergistic therapies for the treatment of traumatic brain injury |
title_short |
Granulocyte-colony stimulating factor and umbilical cord blood cell transplantation: Synergistic therapies for the treatment of traumatic brain injury |
title_full |
Granulocyte-colony stimulating factor and umbilical cord blood cell transplantation: Synergistic therapies for the treatment of traumatic brain injury |
title_fullStr |
Granulocyte-colony stimulating factor and umbilical cord blood cell transplantation: Synergistic therapies for the treatment of traumatic brain injury |
title_full_unstemmed |
Granulocyte-colony stimulating factor and umbilical cord blood cell transplantation: Synergistic therapies for the treatment of traumatic brain injury |
title_sort |
granulocyte-colony stimulating factor and umbilical cord blood cell transplantation: synergistic therapies for the treatment of traumatic brain injury |
publisher |
Wolters Kluwer Medknow Publications |
series |
Brain Circulation |
issn |
2394-8108 2455-4626 |
publishDate |
2017-01-01 |
description |
Traumatic brain injury (TBI) is now characterized as a progressive, degenerative disease and continues to stand as a prevalent cause of death and disability. The pathophysiology of TBI is complex, with a variety of secondary cell death pathways occurring which may persist chronically following the initial cerebral insult. Current therapeutic options for TBI are minimal, with surgical intervention or rehabilitation therapy existing as the only viable treatments. Considering the success of stem-cell therapies in various other neurological diseases, their use has been proposed as a potential potent therapy for patients suffering TBI. Moreover, stem cells are highly amenable to adjunctive use with other therapies, providing an opportunity to overcome the inherent limitations of using a single therapeutic agent. Our research has verified this additive potential by demonstrating the efficacy of co-delivering human umbilical cord blood (hUCB) cells with granulocyte-colony stimulating factor (G-CSF) in a murine model of TBI, providing encouraging results which support the potential of this approach to treat patients suffering from TBI. These findings justify ongoing research toward uncovering the mechanisms which underlie the functional improvements exhibited by hUCB + G-CSF combination therapy, thereby facilitating its safe and effect transition into the clinic. This paper is a review article. Referred literature in this paper has been listed in the reference section. The datasets supporting the conclusions of this article are available online by searching various databases, including PubMed. Some original points in this article come from the laboratory practice in our research center and the authors' experiences. |
topic |
Central nervous system disorders granulocyte-colony stimulating factor human umbilical cord blood regenerative medicine stem-cell therapy traumatic brain injury |
url |
http://www.braincirculation.org/article.asp?issn=2394-8108;year=2017;volume=3;issue=3;spage=143;epage=151;aulast=Liska |
work_keys_str_mv |
AT michaelgliska granulocytecolonystimulatingfactorandumbilicalcordbloodcelltransplantationsynergistictherapiesforthetreatmentoftraumaticbraininjury AT ikedelapena granulocytecolonystimulatingfactorandumbilicalcordbloodcelltransplantationsynergistictherapiesforthetreatmentoftraumaticbraininjury |
_version_ |
1725948901273370624 |